5% in 2007 to 48.5% in 2012. However the prevalent patients remaining on peritoneal dialysis dropped from 91.4% in 2007 to 66.9% in 2012, amounting

to drop of 24.5%. Among the causes that lead to downward trend during the above period was that more patients were being transplanted accounting to 16.1% in 2012 compared to 6.1% in 2007 followed by other causes like being palliated, infection and transferred to haemodialysis and other centres. Conclusion: The results of our study showed that although the incident patients entering the peritoneal dialysis programme increased, there is a downward trend in patients remaining on peritoneal dialysis at our centre as more patients are being transplanted Selleckchem BEZ235 and palliated. 250 OPTIMISING PAEDIATRIC DIALYSIS: A COMPARISON OF ADAPTED AND CONVENTIONAL PERITONEAL DIALYSIS L SHAW1, Z MILLARD1, C QUINLAN1,2 1The Royal Children’s Hospital, Melbourne, Victoria; 2The Murdoch Children’s Research Institute, Melbourne, Victoria, Australia Aim: To compare the efficacy of Conventional peritoneal dialysis (Con-PD) and Adapted PD (Ad-PD) in children. Background: Con-PD is delivered as a series of identical exchanges. Ad-PD consists of several initial

short, low volume cycles, followed by several long, higher volume cycles. A recent randomised trial by Fischbach et al. showed significantly increased ultrafiltration (UF) and greater clearance of urea, creatinine and phosphate

Alvelestat solubility dmso with lower metabolic cost as measured by glucose absorption in a trial in 19 adults. Methods: Patients are randomised to 6 weeks of Ad-PD followed by 6 weeks of Con-PD or vice versa. All patients are seen 2-weekly for clinical assessment and assessment of dialysis adequacy using electrolyte samples of blood, urine and dialysate. Results: This is an ongoing study, to date 9 children have been recruited and 3 have commenced Ad-PD. The first 2 were low transporters and were withdrawn in the first week due to Rho a clinically significant decrease in UF volume. The third child was a high transporter and had a significant increase in UF (from 100 to 400 mL) and a significant decrease in phosphate and potassium, such that supplementation was commenced. We await the full results which will be presented at the meeting. Conclusion: The results of the adults Ad-PD trial were very encouraging but the initial results from our study, the first paediatric trial of Ad-PD, show that it does not work for every child. However the child that had increased UF was failing Con-PD with consideration of haemodialysis and thus this has been an excellent result for her. It is possible that outcomes are dependent on transporter status but further results are necessary to confirm this initial finding.